#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study on Hepatocellular Carcinoma: Evaluating Livmoniplimab and Budigalimab for Patients with Advanced or Metastatic Cancer After First-Line Treatment

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy Spain

  • Study on Regorafenib and Pembrolizumab for Patients with Intermediate-Stage Liver Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Italy Romania Spain

  • Study of Ezurpimtrostat with Atezolizumab and Bevacizumab for Patients with Unresectable Liver Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on the Effects of Volrustomig and Drug Combination for Patients with Advanced Hepatobiliary Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy Spain

  • Study of Relatlimab and Nivolumab for Patients with Advanced Liver Cancer Who Have Not Received Immunotherapy After Tyrosine Kinase Inhibitor Treatment

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Poland Romania Spain

  • Study of Pembrolizumab as Additional Treatment for Patients with Liver Cancer (Hepatocellular Carcinoma) After Surgery or Local Ablation

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark France Germany Hungary Ireland +5

  • Study of Subcutaneous Nivolumab with or without Recombinant Human Hyaluronidase PH20 for Patients with Lung, Kidney, Melanoma, Liver, Colorectal, or Bladder Cancer

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    France Italy The Netherlands Poland Spain

  • Study on the Effectiveness of 188Re-SSS Lipiodol Therapy for Patients with Non-Operable Liver Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study of Pembrolizumab and Lenvatinib with TACE for Patients with Incurable Non-metastatic Liver Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark France Germany Hungary Ireland Italy +3

  • Study on the Safety and Effectiveness of MK-1308A, Pembrolizumab, and Lenvatinib for Patients with Advanced Liver Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Italy Poland Spain